Qiuhong Zhao Selected Research

ibrutinib

12/2023	Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in USA: A Real World Analysis.
1/2022	Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
1/2022	Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation.
11/2019	Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib.
10/2019	Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies.
1/2018	Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies.
9/2017	Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiuhong Zhao Research Topics

Disease

8	Neoplasms (Cancer) 11/2022 - 01/2018
7	Multiple Myeloma 12/2023 - 01/2020
7	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2021 - 10/2012
6	Hemorrhage 11/2018 - 07/2012
4	Lymphoma (Lymphomas) 12/2023 - 10/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2023 - 01/2020
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 02/2021
3	Stroke (Strokes) 01/2022 - 09/2017
3	Pain (Aches) 02/2018 - 11/2012
2	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2021
2	Disease Progression 09/2022 - 01/2022
2	Thrombotic Microangiopathies 01/2022 - 10/2018
2	Infections 11/2021 - 01/2021
2	Ectopic Pregnancy 01/2021 - 05/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2020 - 01/2019
2	Weight Gain 10/2013 - 01/2013
2	Overweight 03/2013 - 07/2012
1	Hyponatremia 09/2023
1	Febrile Neutropenia 01/2023
1	Mucositis 01/2023
1	Sudden Death 11/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2022
1	Heart Failure 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Leukemia 01/2022
1	Myocardial Infarction 01/2022
1	Obesity 01/2022
1	Death (Near-Death Experience) 01/2022
1	Isolated Systolic Hypertension 01/2022
1	Migraine Disorders (Migraine) 10/2021
1	Reproductive Tract Infections 01/2021
1	Infertility (Sterility) 01/2021
1	Abnormal Karyotype 12/2020
1	Immunoglobulin Light-chain Amyloidosis 11/2020
1	Venous Thromboembolism 09/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2020
1	Lung Neoplasms (Lung Cancer) 05/2020
1	Thrombosis (Thrombus) 11/2019
1	Opportunistic Infections (Opportunistic Infection) 10/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Menorrhagia 11/2018
1	Dysmenorrhea (Menstrual Pain) 02/2018
1	Atrial Fibrillation 09/2017
1	Hematologic Neoplasms (Hematological Malignancy) 09/2017

Drug/Important Bio-Agent (IBA)

8	Contraceptive Agents (Contraceptives)IBA 01/2021 - 09/2011
7	ibrutinibIBA 12/2023 - 09/2017
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2020
3	CopperIBA 02/2018 - 10/2013
2	selinexorIBA 09/2023 - 01/2020
2	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 01/2023
2	acalabrutinibIBA 11/2022 - 01/2022
2	Agammaglobulinaemia Tyrosine KinaseIBA 11/2022 - 01/2022
2	Lenalidomide (CC 5013)FDA Link 12/2020 - 01/2020
2	Decitabine FDA Link 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2012
2	Levonorgestrel (Plan B)FDA LinkGeneric 02/2018 - 10/2013
2	Lidocaine (Xylocaine)FDA LinkGeneric 01/2014 - 11/2012
2	etonogestrel (Implanon)FDA Link 10/2013 - 07/2012
2	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 10/2013 - 01/2013
1	ParaproteinsIBA 12/2023
1	carfilzomibIBA 12/2023
1	trioctyl phosphine oxide (TOPO)IBA 09/2023
1	Prostaglandins FIBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 11/2021
1	letermovirIBA 11/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2021
1	Serum AlbuminIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 12/2020
1	pegaspargase (Oncaspar)FDA Link 09/2020
1	Circular RNAIBA 05/2020
1	Vorinostat FDA Link 01/2020
1	thiamine triphosphorate (TTP)IBA 01/2019
1	IGF-I-IGFBP-3 complex FDA Link 01/2019
1	Complement System Proteins (Complement)IBA 10/2018
1	SteroidsIBA 10/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2017
1	Anesthetics (Anesthetic Agents)IBA 01/2014
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2014
1	Progestins (Progestagens)IBA 10/2013

Therapy/Procedure

10	Contraception (Birth Control) 01/2022 - 01/2013
8	Therapeutics 01/2023 - 01/2020
7	Intrauterine Devices (Intrauterine Device) 10/2021 - 07/2012
5	Drug Therapy (Chemotherapy) 09/2023 - 01/2019
5	Cell Transplantation 01/2023 - 10/2019
5	Copper Intrauterine Devices 11/2021 - 01/2013
4	Long-Acting Reversible Contraception 10/2021 - 01/2013
4	Stem Cell Transplantation 02/2021 - 10/2019
4	Condoms (Condom) 04/2018 - 10/2012
3	Aftercare (After-Treatment) 01/2019 - 07/2012
2	Autologous Transplantation 02/2022 - 01/2020
2	Contraceptive Effectiveness 03/2013 - 07/2012
1	Induction Chemotherapy 01/2023
1	Hematopoietic Stem Cell Transplantation 11/2022
1	Transplantation 02/2021
1	Salvage Therapy 10/2019